The molecular mechanism of how the insulin receptor signaling pathway affects macrophage function remains to be further defined, but the present study suggests that this may offer a site for pharmacological intervention that could lead to novel therapeutic strategies for metabolic diseases. The gene discussed is INSR; the disease is metabolic disease.